Inhaled carbon monoxide attenuates myocardial inflammatory cytokine expression in a rat model of cardiopulmonary bypass
- PMID: 22164452
- PMCID: PMC3307597
Inhaled carbon monoxide attenuates myocardial inflammatory cytokine expression in a rat model of cardiopulmonary bypass
Abstract
Carbon monoxide (CO), a by-product of Heme metabolism, is a potent modulator of inflammation. Low dose inhaled CO has demonstrated reduced lung and kidney injury in animal models of cardiopulmonary bypass (CPB). We evaluated the impact of low dose inhaled CO on systemic, pulmonary, and myocardial inflammatory response to CPB in rats. Sixteen male Sprague-Dawley rats underwent CPB for 1 hour. The CO (n = 8) group received inhaled CO at 250 ppm for 3 hours before CPB. The Air (n = 8) group served as the control. Pulmonary mechanics were assessed pre and post CPB. The animals were recovered for 30 minutes post CPB and subsequently sacrificed. Pre CPB and post CPB serum Tumor Necrosis Factor-alpha (TNF-alpha) and Interleukin-10 (IL-10) were analyzed by enzyme-linked immunosorbent assay. Gene expression array and real time quantitative polymerase chain reaction (PCR) analysis was performed on the extracted heart tissue. Baseline characteristics were similar between the groups with the expected exception of carboxyhemoglobin levels (p < or = .001) and oxyhemoglobin saturation (p < or = .01) in Air versus CO treated groups, respectively. Serum TNF-alpha (363 +/- 278 vs. 287 +/- 195;p = .13) and IL-10 (237 +/- 26 vs. 302 +/- 137; p = Not Significant) in Air versus CO groups respectively were not statistically different after CPB, despite showing a trend of inflammatory attenuation. Gene expression array of the myocardial tissue suggested a pattern of inflammatory modulation, which was confirmed by real time quantitative PCR demonstrating IL-10 expression 3.13 times higher (p = .02) in the CO treated group compared to the Air group. These data demonstrate that pretreatment with CO at 250 ppm may have a modulatory effect on the inflammatory response to CPB without compromising hemodynamics or oxygen delivery. Further investigation in a survival model of CPB is warranted.
Conflict of interest statement
This study was supported by BAYER fellowship in blood conservation and NIH grants DK57061 and 52766. The senior author has stated that authors have reported no material, financial, or other relationship with any healthcare-related business or other entity whose products or services are discussed in this paper.
Figures



Similar articles
-
Reduced pulmonary inflammatory response during cardiopulmonary bypass: effects of combined pulmonary perfusion and carbon monoxide inhalation.Eur J Cardiothorac Surg. 2008 Dec;34(6):1165-72. doi: 10.1016/j.ejcts.2008.07.031. Epub 2008 Oct 1. Eur J Cardiothorac Surg. 2008. PMID: 18829339
-
Carbon monoxide inhalation reduces pulmonary inflammatory response during cardiopulmonary bypass in pigs.Anesthesiology. 2008 Jun;108(6):1025-36. doi: 10.1097/ALN.0b013e3181733115. Anesthesiology. 2008. PMID: 18497603
-
Inhaled carbon monoxide prevents acute kidney injury in pigs after cardiopulmonary bypass by inducing a heat shock response.Anesth Analg. 2010 Jul;111(1):29-37. doi: 10.1213/ANE.0b013e3181e0cca4. Epub 2010 Jun 2. Anesth Analg. 2010. PMID: 20519418
-
Protective effects of inhaled carbon monoxide in pig lungs during cardiopulmonary bypass are mediated via an induction of the heat shock response.Br J Anaesth. 2009 Aug;103(2):173-84. doi: 10.1093/bja/aep087. Epub 2009 Apr 29. Br J Anaesth. 2009. PMID: 19403594
-
Postconditioning of the lungs with inhaled carbon monoxide after cardiopulmonary bypass in pigs.Anesth Analg. 2011 Feb;112(2):282-91. doi: 10.1213/ANE.0b013e318203f591. Epub 2010 Dec 14. Anesth Analg. 2011. PMID: 21156982
Cited by
-
Surgical and physiological challenges in the development of left and right heart failure in rat models.Heart Fail Rev. 2019 Sep;24(5):759-777. doi: 10.1007/s10741-019-09783-4. Heart Fail Rev. 2019. PMID: 30903356 Free PMC article. Review.
-
Carbon monoxide decreases interleukin-1β levels in the lung through the induction of pyrin.Cell Mol Immunol. 2017 Apr;14(4):349-359. doi: 10.1038/cmi.2015.79. Epub 2015 Oct 19. Cell Mol Immunol. 2017. PMID: 26435068 Free PMC article.
-
Carbon monoxide protects the kidney through the central circadian clock and CD39.Proc Natl Acad Sci U S A. 2018 Mar 6;115(10):E2302-E2310. doi: 10.1073/pnas.1716747115. Epub 2018 Feb 20. Proc Natl Acad Sci U S A. 2018. PMID: 29463714 Free PMC article.
-
Combined treatment of hydroxytyrosol with carbon monoxide-releasing molecule-2 prevents TNF α-induced vascular endothelial cell dysfunction through NO production with subsequent NFκB inactivation.Biomed Res Int. 2013;2013:912431. doi: 10.1155/2013/912431. Epub 2013 Aug 27. Biomed Res Int. 2013. PMID: 24066302 Free PMC article.
References
-
- Wan IY, Arifi AA, Wan S, et al. . Beating heart revascularization with or without cardiopulmonary bypass: Evaluation of inflammatory response in a prospective randomized study. J Thorac Cardiovasc Surg. 2004;127:1624–31. - PubMed
-
- Dong X, Liu Y, Du M, et al. . P38 mitogen-activated protein kinase inhibition attenuates pulmonary inflammatory response in a rat cardiopulmonary bypass model. Eur J Cardiothorac Surg. 2006;30:77–84. - PubMed
-
- Ryter SW, Morse D, Choi AM.. Carbon monoxide: To boldly go where NO has gone before. Sci STKE 2004:RE6. - PubMed
-
- Lavitrano M, Smolenski RT, Musumeci A, et al. . Carbon monoxide improves cardiac energetics and safeguards the heart during reperfusion after cardiopulmonary bypass in pigs. FASEB J. 2004;18:1093–5. - PubMed
-
- Goebel U, Siepe M, Mecklenburg A, et al. . Carbon monoxide inhalation reduces pulmonary inflammatory response during cardiopulmonary bypass in pigs. Anesthesiology. 2008;108:1025–36. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources